Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications
Abstract Graphical abstract: Research shows that currently there is no clinical evidence to support the use of cannabis or any…
Abstract Graphical abstract: Research shows that currently there is no clinical evidence to support the use of cannabis or any…
Abstract The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes…
Abstract To combat the coronaviruses and their novel variants, therapeutic drugs and the development of vaccines that are to be…
Abstract Novel coronavirus 2019 (COVID-19) is a zoonosis that revised the global economic and societal progress since early 2020. The…
Abstract Now a days, more than 200 countries faces the health crisis due to epidemiological disease COVID-19 caused by SARS-CoV-2…
Abstract The activity of a new, terpene-based formulation, code-named NT-VRL-1, against Human Coronavirus (HCoV) strain 229E was evaluated in human…
Abstract Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and…
Abstract Post-traumatic stress disorder (PTSD) is a psychiatric disease that seriously affects brain function. Currently, selective serotonin reuptake inhibitors (SSRIs)…
Abstract Background: The COVID-19 outbreak was designated a global pandemic on March 11, 2020. The relationship between vaping and contracting…
Abstract In response to the Coronavirus Disease 2019 (COVID-19) pandemic, current modeling supports the use of masks in community settings…